Inhibikase Therapeutics discloses no exposure to Silicon Valley Bank

Inhibikase Therapeutics, Inc.

Company holds no cash deposits or lines of credit with SVB.
No business relationship with SVB exists.
Filing aims to reassure investors amid SVB collapse.

item 8.01

Inhibikase Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-069219

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.